Lawmakers Take Investigation into Emflaza’s Price to New Owner, PTC Therapeutics

March 23, 2017

Sen. Bernie Sanders (I-Vt.) and Rep. Elijah Cummings (D-Md.) have not halted their investigation into the pricing of Emflaza, pursuing its sale from Marathon to PTC Therapeutics.
Source: Drug Industry Daily

Posted in Drug Industry Daily